Your browser doesn't support javascript.
loading
Response to "Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis". Response to related letter.
De La Flor, José C; Moral, Esperanza; Deira, Javier; Monzón, Tania; Valga, Francisco; Albarracín, Cristina; Rodeles, Miguel.
Affiliation
  • De La Flor JC; Servicio de Nefrología, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain. Electronic address: josedelaflor81@yahoo.com.
  • Moral E; Servicio de Nefrología, Hospital General de Ciudad Real, Ciudad Real, Spain.
  • Deira J; Servicio de Nefrología, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Monzón T; Servicio de Nefrología, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canarias, Spain.
  • Valga F; Servicio de Nefrología, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canarias, Spain.
  • Albarracín C; Servicio de Nefrología, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.
  • Rodeles M; Servicio de Nefrología, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.
Nefrologia (Engl Ed) ; 44(3): 444-446, 2024.
Article in En | MEDLINE | ID: mdl-38862303
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Peritoneal Dialysis / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Hypoglycemic Agents / Obesity Limits: Humans Language: En Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Peritoneal Dialysis / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Hypoglycemic Agents / Obesity Limits: Humans Language: En Year: 2024 Type: Article